Breaking News Instant updates and real-time market news.

2020-12-11 06:04:22 JOUT Johnson Outdoors $90.97 / +3.65 (+4.18%) 06:04 12/11/20 12/11 06:04 12/11/20 06:04	Johnson Outdoors reports Q4 EPS $1.53, one estimate 80c Reports Q4 revenue $164.68M, one estimate $125.44M.	11 Dec
JOUT Johnson Outdoors $90.97 / +3.65 (+4.18%) 09/08/20 Sidoti Johnson Outdoors upgraded to Buy from Neutral at Sidoti 03/06/20 Johnson Outdoors management to meet with Oppenheimer 01/07/20 Johnson Outdoors management to meet with Sidoti

2020-12-11 06:04:22

JOUT

Johnson Outdoors

$90.97 / +3.65 (+4.18%)

06:04

12/11/20

12/11

06:04

12/11/20

06:04

Johnson Outdoors reports Q4 EPS $1.53, one estimate 80c

Reports Q4 revenue $164.68M, one estimate $125.44M.

11
Dec

JOUT Johnson Outdoors

$90.97 / +3.65 (+4.18%)

09/08/20 Sidoti: Johnson Outdoors upgraded to Buy from Neutral at Sidoti

03/06/20: Johnson Outdoors management to meet with Oppenheimer

01/07/20: Johnson Outdoors management to meet with Sidoti

TODAY'S FREE FLY STORIES

Downgrade	Air France-KLM downgraded to Reduce from Hold at Kepler Cheuvreux » 05:18 01/22/21 01/22 05:18 01/22/21 05:18 AFLYY Air France-KLM $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals AFLYY Air France-KLM $0.00 / + (+0.00%) 12/04/20 KLM, Delta to offer COVID-19 tested flights from Atlanta to Amsterdam AFLYY Air France-KLM $0.00 / + (+0.00%) 01/20/21 Barclays Air France-KLM price target raised to EUR 5.10 from EUR 2.70 at Barclays 12/04/20 Deutsche Bank Air France-KLM price target raised to EUR 3.50 from EUR 2.10 at Deutsche Bank 12/01/20 UBS Air France-KLM price target raised to EUR 4.45 from EUR 3.35 at UBS 11/12/20 Kepler Cheuvreux Air France-KLM upgraded to Hold from Reduce at Kepler Cheuvreux AFLYY Air France-KLM $0.00 / + (+0.00%) 07/30/20 Air France-KLM sees 'significantly negative' EBITDA in second half 07/30/20 Air France-KLM reports Q2 revenue EUR 1.18B vs. EUR 7.02B last year AFLYY Air France-KLM $0.00 / + (+0.00%) 12/22/20 Germany extends U.K. travel ban to January 6, Sky News reports 09/24/20 KLM steps up labor talks aimed to securing wage cuts, Bloomberg reports 09/01/20 Air France-KLM plans to raise funds by May of next year, Bloomberg reports
Downgrade	Alstom downgraded to Hold from Buy at Kepler Cheuvreux » 05:17 01/22/21 01/22 05:17 01/22/21 05:17 ALSMY Alstom $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals ALSMY Alstom $0.00 / + (+0.00%) 12/01/20 Bombardier, Alstom confirm receipt of all necessary approvals for transaction 09/16/20 Bombardier announces SPA for sale of transportation business to Alstom 07/31/20 European Commission clears Alstom's acquisition of Bombardier Transportation 07/28/20 Linde to begin construction on hydrogen refueling station for trains in Germany ALSMY Alstom $0.00 / + (+0.00%) 01/20/21 Jefferies Alstom upgraded to Buy from Hold at Jefferies 01/12/21 Deutsche Bank Alstom price target raised to EUR 47 from EUR 45 at Deutsche Bank 12/11/20 Credit Suisse Alstom upgraded to Outperform from Neutral at Credit Suisse 12/08/20 Morgan Stanley Alstom price target raised to EUR 55 from EUR 51 at Morgan Stanley ALSMY Alstom $0.00 / + (+0.00%) 07/27/20 EU set to approve with conditions Alstom, Bombardier deal, Reuters reports
Downgrade	IAG downgraded to Reduce from Hold at Kepler Cheuvreux » 05:17 01/22/21 01/22 05:17 01/22/21 05:17 ICAGY IAG $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals ICAGY IAG $0.00 / + (+0.00%) 07/24/20 IAG 'evaluating the merits of a rights issue' of up to EUR 2.75B ICAGY IAG $0.00 / + (+0.00%) 01/20/21 Barclays IAG price target raised to 175 GBp from 120 GBp at Barclays 12/31/20 Fly Intel: Top five analyst calls 12/31/20 Citi IAG upgraded to Buy from Neutral at Citi 12/04/20 Deutsche Bank IAG price target raised to 220 GBp from 175 GBp at Deutsche Bank ICAGY IAG $0.00 / + (+0.00%) 12/07/20 IAG dismisses Ryanair comments on British Airways holding, Reuters says 11/05/20 British Airways to reduce flight schedule in November, Reuters reports
Upgrade	Adient upgraded to Neutral from Underweight at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 ADNT Adient $35.26 / -0.71 (-1.97%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ADNT Adient $35.26 / -0.71 (-1.97%) 08/14/20 Greenlight Capital exits Altice, takes stake in Atlas Air ADNT Adient $35.26 / -0.71 (-1.97%) 01/20/21 Deutsche Bank Adient price target raised to $43 from $37 at Deutsche Bank 12/17/20 Barclays Adient price target raised to $45 from $37 at Barclays 12/16/20 KeyBanc Adient price target raised to $43 from $36 at KeyBanc 12/02/20 Deutsche Bank Adient price target raised to $37 from $27 at Deutsche Bank ADNT Adient $35.26 / -0.71 (-1.97%) 11/30/20 Adient sees FY21 revenue $14.6B-$15B, consensus $14.47B 11/30/20 Adient reports Q4 adj. EPS $1.15, consensus 71c 08/06/20 Adient sees Q4 revenue $3.3B-$3.5B, consensus $3.31B 08/06/20 Adient reports Q3 adj. EPS ($2.78), consensus ($2.08) 02/05/21 Adient - ADNT
Downgrade	Gentherm downgraded to Underweight from Neutral at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 THRM Gentherm $70.38 / -0.6 (-0.85%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings THRM Gentherm $70.38 / -0.6 (-0.85%) 01/11/21 Gentherm appoints Betsy Meter to board of directors 01/04/21 Gentherm appoints Steve Fletcher as SVP, GM of Medical 10/29/20 Gentherm to delay Q3 conference call 10/15/20 Gentherm launches ASTOPAD Patient Warming System THRM Gentherm $70.38 / -0.6 (-0.85%) 12/23/20 Barrington Gentherm double downgraded to Underperform at Barrington following rally 12/23/20 Barrington Gentherm downgraded to Underperform from Outperform at Barrington 10/30/20 Roth Capital Gentherm price target raised to $53 from $44 at Roth Capital 10/22/20 JPMorgan Gentherm price target raised to $48 from $43 at JPMorgan THRM Gentherm $70.38 / -0.6 (-0.85%) 10/29/20 Gentherm sees Q4 product revenues $240M-$260M, consensus $228.41M 10/29/20 Gentherm reports Q3 adjusted EPS 91c, consensus 49c 08/04/20 Gentherm not providing update to FY20 guidance 08/04/20 Gentherm sees Q3 product revenues $210M-$240M, consensus $212.53M

Upgrade	Lear upgraded to Overweight from Neutral at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 LEA Lear $168.15 / +0.79 (+0.47%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LEA Lear $168.15 / +0.79 (+0.47%) 01/14/21 Cerence, Xevo collaborate for to deliver Cerence Pay payment capabilities 01/11/21 Lear partners with GrubHub to deliver ordering capabilities in FCA vehicles 11/18/20 Lear reinstates quarterly cash dividend at 25c per share 11/16/20 Paulson & Co. buys Lear, cuts Tiffany in Q3 LEA Lear $168.15 / +0.79 (+0.47%) 01/20/21 Deutsche Bank Lear price target raised to $165 from $150 at Deutsche Bank 01/08/21 Guggenheim Lear downgraded to Neutral from Buy at Guggenheim 12/17/20 Barclays Lear upgraded to Overweight from Equal Weight at Barclays 12/16/20 Argus Lear upgraded to Buy at Argus on high expected demand following COVID LEA Lear $168.15 / +0.79 (+0.47%) 10/30/20 Lear reinstates FY20 revenue view $16.35B-$16.65B, consensus $16.45B 10/30/20 Lear reports Q3 adj. EPS $3.73, consensus $3.14 08/04/20 Lear not providing FY20 guidance due to COVID-19 08/04/20 Lear reports Q2 adj. EPS ($4.14), consensus ($4.67) LEA Lear $168.15 / +0.79 (+0.47%) 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 02/04/21 Lear - LEA
Downgrade	Visteon downgraded to Underweight from Neutral at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 VC Visteon $142.17 / +0.6 (+0.42%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VC Visteon $142.17 / +0.6 (+0.42%) 12/07/20 Cognex names Visteon CEO Lawande to board of directors VC Visteon $142.17 / +0.6 (+0.42%) 01/20/21 Deutsche Bank Visteon price target raised to $166 from $105 at Deutsche Bank 12/17/20 Barclays Visteon price target raised to $150 from $101 at Barclays 11/19/20 Baird Visteon price target raised to $130 from $105 at Baird 11/03/20 Goldman Sachs Visteon upgraded to Neutral from Sell at Goldman Sachs VC Visteon $142.17 / +0.6 (+0.42%) 10/29/20 Visteon reports Q3 adjusted EPS $1.36, consensus 50c 07/30/20 Visteon reports Q2 EPS ($1.62), consensus ($2.12)
Downgrade	Aptiv downgraded to Neutral from Overweight at JPMorgan » 05:15 01/22/21 01/22 05:15 01/22/21 05:15 APTV Aptiv $143.95 / -1.16 (-0.80%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly Events APTV Aptiv $143.95 / -1.16 (-0.80%) 01/20/21 Deutsche Bank Aptiv price target raised to $160 from $120 at Deutsche Bank 12/22/20 Citi Citi 'very skeptical' of Apple car, says Tesla most direct competitor 12/17/20 Barclays Aptiv price target raised to $145 from $112 at Barclays 12/16/20 Argus Aptiv initiated with a Buy at Argus on 'attractive valuation' APTV Aptiv $143.95 / -1.16 (-0.80%) 10/29/20 Aptiv sees FY20 adj. EPS $1.65-$1.80, consensus $1.28 10/29/20 Aptiv reports Q3 ex-items EPS $1.13, consensus 76c 07/30/20 Aptiv not reporting Q3, FY20 guidance at this time 07/30/20 Aptiv reports Q2 EPS ex-items ($1.10), consensus ($1.38) 10 Jun APTV Aptiv $143.95 / -1.16 (-0.80%) 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/22/20 Apple rises as Wall Street digests report of self-driving car plans 09/18/20 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/03/21 Aptiv - APTV
Downgrade	TGS-NOPEC downgraded to Sell from Neutral at UBS » 05:15 01/22/21 01/22 05:15 01/22/21 05:15 TGSGY TGS-NOPEC $0.00 / + (+0.00%) UBS analyst Amy Wong… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TGSGY TGS-NOPEC $0.00 / + (+0.00%) 10/09/20 UBS TGS-NOPEC price target lowered to NOK 135 from NOK 145 at UBS 10/09/20 DNB Markets TGS-NOPEC downgraded to Sell from Hold at DNB Markets 10/09/20 Danske Bank TGS-NOPEC downgraded to Hold from Buy at Danske Bank 08/19/20 Fearnley TGS-NOPEC downgraded to Sell from Buy at Fearnley
Downgrade	Bunzl downgraded to Equal Weight from Overweight at Barclays » 05:14 01/22/21 01/22 05:14 01/22/21 05:14 BZLFF Bunzl $0.00 / + (+0.00%) Barclays analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Downgrade	Vifor Pharma downgraded to Sell from Neutral at UBS » 05:13 01/22/21 01/22 05:13 01/22/21 05:13 GNHAF Vifor Pharma / + UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GNHAF Vifor Pharma / + 11/09/20 Vifor Pharma, Angion sign licensing agreement for ANG-3777 commercialization 10/20/20 Vifor Pharma, Cara Therapeutics enter license agreement for Korsuva Injection GNHAF Vifor Pharma / + 05:13 Today UBS Vifor Pharma downgraded to Sell from Neutral at UBS 01/04/21 JPMorgan Vifor Pharma downgraded to Underweight from Neutral at JPMorgan 10/22/20 Credit Suisse Vifor Pharma price target lowered to CHF 149 from CHF 152 at Credit Suisse 10/21/20 JPMorgan Vifor Pharma price target lowered to CHF 130 from CHF 175 at JPMorgan
Downgrade	Vifor Pharma downgraded to Sell from Neutral at UBS » 05:13 01/22/21 01/22 05:13 01/22/21 05:13 GNHAF Vifor Pharma $0.00 / + (+0.00%) UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GNHAF Vifor Pharma $0.00 / + (+0.00%) 11/09/20 Vifor Pharma, Angion sign licensing agreement for ANG-3777 commercialization 10/20/20 Vifor Pharma, Cara Therapeutics enter license agreement for Korsuva Injection GNHAF Vifor Pharma $0.00 / + (+0.00%) 01/04/21 JPMorgan Vifor Pharma downgraded to Underweight from Neutral at JPMorgan 10/22/20 Credit Suisse Vifor Pharma price target lowered to CHF 149 from CHF 152 at Credit Suisse 10/21/20 JPMorgan Vifor Pharma price target lowered to CHF 130 from CHF 175 at JPMorgan 10/21/20 UBS Vifor Pharma price target lowered to CHF 129 from CHF 142 at UBS
Earnings	Chemung Financial reports Q4 EPS $1.11, consensus $1.02 » 05:11 01/22/21 01/22 05:11 01/22/21 05:11 CHMG Chemung Financial $33.76 / -1.16 (-3.32%) Reports Q4 net… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CHMG Chemung Financial $33.76 / -1.16 (-3.32%) 01/08/21 Chemung Financial announces 250,000 share repurchase program CHMG Chemung Financial $33.76 / -1.16 (-3.32%) 10/22/20 DA Davidson Chemung Financial downgraded to Neutral from Buy at DA Davidson 03/09/20 DA Davidson Chemung Financial upgraded to Buy from Neutral at DA Davidson CHMG Chemung Financial $33.76 / -1.16 (-3.32%) 10/19/20 Chemung Financial reports Q3 EPS $1.19, consensus 67c
Downgrade	Sage Therapeutics downgraded to Market Perform from Outperform at BMO Capital » 05:08 01/22/21 01/22 05:08 01/22/21 05:08 SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) BMO Capital analyst Gary… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 01/07/21 Sage Therapeutics plans to advance SAGE-319, SAGE-421 to preclinical studies 12/16/20 Sage Therapeutics names Barry Greene as CEO 11/27/20 Sage Therapeutics trading resumes 11/27/20 Sage Therapeutics to resume trading at 8 am ET SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 01/19/21 Wedbush Sage Therapeutics price target raised to $98 from $83 at Wedbush 01/04/21 Sage Therapeutics downgraded to Sector Perform at RBC Capital on valuation 01/04/21 Guggenheim Sage Therapeutics upgraded to Buy from Neutral at Guggenheim 01/04/21 RBC Capital Sage Therapeutics downgraded to Sector Perform from Outperform at RBC Capital SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 11/05/20 Sage Therapeutics reports Q3 EPS ($2.03), consensus ($2.39) 08/10/20 Sage Therapeutics reports Q2 EPS ($2.63), consensus ($2.66) SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 12/04/20 Delta, United, Boeing downgrades among today's top calls on Wall Street 11/27/20 Fly Intel: Wall Street's top stories for Friday 11/27/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference
Downgrade	Regis downgraded to Hold from Buy at Jefferies » 05:07 01/22/21 01/22 05:07 01/22/21 05:07 RGS Regis $9.25 / +0.195 (+2.15%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly RGS Regis $9.25 / +0.195 (+2.15%) 12/02/20 Regis announces brand-centric reorganization 11/29/20 Fly Intel: Top five weekend stock stories 11/02/20 Regis falls -9.0% 11/02/20 Regis says about 80% of company's salon portfolio franchised at Q1-end RGS Regis $9.25 / +0.195 (+2.15%) 10/30/20 B. Riley Securities Regis price target raised to $160 from $155 at B. Riley Securities 10/22/20 Loop Capital Regis downgraded to Hold from Buy at Loop Capital 10/22/20 Loop Capital Regis downgraded to Hold from Buy at Loop Capital 06/19/20 Loop Capital Regis price target lowered to $15 from $21 at Loop Capital RGS Regis $9.25 / +0.195 (+2.15%) 11/02/20 Regis reports Q1 adjusted EPS (78c), consensus (12c) 08/31/20 Regis reports Q4 adjusted EPS ($1.01), consensus (66c) RGS Regis $9.25 / +0.195 (+2.15%) 11/28/20 Supercuts owner Regis stock a post-COVID play, Barron's says RGS Regis $9.25 / +0.195 (+2.15%) 11/02/20 Fly Intel: Pre-market Movers 08/31/20 Fly Intel: Wall Street's top stories for Monday 08/31/20 Fly Intel: Wall Street's top stories at midday 08/31/20 Fly Intel: Pre-market Movers

Upgrade	Seagate upgraded to Buy from Hold at Summit Insights » 05:07 01/22/21 01/22 05:07 01/22/21 05:07 STX Seagate $63.00 / +1.57 (+2.56%) Summit Insights analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate says 2020 'a very challenging year' 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products STX Seagate $63.00 / +1.57 (+2.56%) 05:04 Today Benchmark Seagate price target raised to $70 from $60 at Benchmark 01/21/21 Barclays Seagate price target raised to $60 from $41 at Barclays 01/20/21 Wedbush Seagate price target raised to $56 from $47 at Wedbush 01/19/21 Northland Seagate price target raised to $72 from $65 at Northland STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate sees Q3 adjusted EPS $1.30, plus/minus 15c, consensus $1.26 01/21/21 Seagate reports Q2 adjusted EPS $1.29, consensus $1.13 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Fly Intel: After-Hours Movers 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate options imply 7.9% move in share price post-earnings 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish
Downgrade	CSX downgraded to Hold from Buy at Stifel » 05:06 01/22/21 01/22 05:06 01/22/21 05:06 CSX CSX $91.61 / -1.6101 (-1.73%) Stifel analyst David Ross… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CSX CSX $91.61 / -1.6101 (-1.73%) 01/20/21 North American rail traffic rose 8.6% in the week ended January 16 01/14/21 North American rail traffic rose 3% in the week ended January 9 01/07/21 North American rail traffic rose 1.3% in the week ended January 2 12/31/20 North American rail traffic rose 7% in week ended December 26 CSX CSX $91.61 / -1.6101 (-1.73%) 01/20/21 Susquehanna Railroad recovery expected to continue in 2021, says Susquehanna 01/11/21 Citi CSX price target raised to $105 from $87 at Citi 12/10/20 Morgan Stanley Morgan Stanley downgrades CSX to Underweight with bar raised too high 12/10/20 Morgan Stanley CSX downgraded to Underweight from Equal Weight at Morgan Stanley CSX CSX $91.61 / -1.6101 (-1.73%) 01/21/21 CSX reports Q4 EPS 99c, consensus $1.00 01/21/21 Notable companies reporting after market close 10/21/20 CSX reports Q3 EPS 96c, consensus 92c 10/21/20 Notable companies reporting after market close CSX CSX $91.61 / -1.6101 (-1.73%) 01/21/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: After-Hours Movers CSX CSX $91.61 / -1.6101 (-1.73%) 01/21/21 CSX options imply 4.6% move in share price post-earnings 10/22/20 Early notable gainers among liquid option names on October 22nd 09/15/20 CSX call volume above normal and directionally bullish 09/04/20 CSX put volume heavy and directionally bearish
Upgrade	PacWest Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette » 05:05 01/22/21 01/22 05:05 01/22/21 05:05 PACW PacWest Bancorp $30.33 / +0.345 (+1.15%) Keefe Bruyette analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings PACW PacWest Bancorp $30.33 / +0.345 (+1.15%) 01/12/21 Fly Intel: Top five analyst initiations 01/12/21 Piper Sandler PacWest Bancorp assumed with an Overweight at Piper Sandler 01/04/21 Wells Fargo PacWest Bancorp upgraded to Overweight from Equal Weight at Wells Fargo 12/15/20 Truist Truist raises price targets on select regional banks PACW PacWest Bancorp $30.33 / +0.345 (+1.15%) 01/20/21 PacWest Bancorp reports Q4 EPS 99v, consensus 67v 10/14/20 PacWest Bancorp reports Q3 EPS 38c, consensus 63c
Recommendations	Seagate price target raised to $70 from $60 at Benchmark » 05:04 01/22/21 01/22 05:04 01/22/21 05:04 STX Seagate $63.00 / +1.57 (+2.56%) Benchmark analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate says 2020 'a very challenging year' 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Barclays Seagate price target raised to $60 from $41 at Barclays 01/20/21 Wedbush Seagate price target raised to $56 from $47 at Wedbush 01/19/21 Northland Seagate price target raised to $72 from $65 at Northland 01/19/21 Loop Capital Seagate price target raised to $70 from $60 at Loop Capital STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate sees Q3 adjusted EPS $1.30, plus/minus 15c, consensus $1.26 01/21/21 Seagate reports Q2 adjusted EPS $1.29, consensus $1.13 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Fly Intel: After-Hours Movers 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate options imply 7.9% move in share price post-earnings 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish
Recommendations	Intuitive Surgical price target raised to $730 from $680 at Piper Sandler » 05:02 01/22/21 01/22 05:02 01/22/21 05:02 ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 01/21/21 Intuitive Surgical says overall procedure growth was 6% in Q4 10/27/20 Intuitive Surgical launches $100M venture capital fund 10/15/20 Intuitive Surgical slides 2.8% to $720 per share after Q3 results 10/15/20 Intuitive Surgical's first 9 months of 2020 saw 'significant impact' from COVID ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 12/15/20 Morgan Stanley Intuitive Surgical downgraded to Equal Weight on valuation at Morgan Stanley 12/15/20 Morgan Stanley Intuitive Surgical downgraded to Equal Weight from Overweight at Morgan Stanley 11/24/20 Raymond James Intuitive Surgical not surprised by J&J robot features, says Raymond James 10/16/20 JPMorgan Intuitive Surgical price target raised to $785 from $765 at JPMorgan ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 01/21/21 Intuitive Surgical reports Q4 EPS $3.58, consensus $3.12 01/21/21 Notable companies reporting after market close 01/13/21 Intuitive Surgical sees 2020 revenue $4.36B, consensus $4.27B 01/13/21 Intuitive Surgical sees Q4 revenue $1.33B, consensus $1.23B ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 01/21/21 Fly Intel: After-Hours Movers 10/15/20 Fly Intel: After-Hours Movers ISRG Intuitive Surgical $799.43 / -0.18 (-0.02%) 11/12/20 Early notable gainers among liquid option names on November 12th 10/15/20 Intuitive Surgical options imply 5.8% move in share price post-earnings

Initiation	HubSpot initiated with an Outperform at BMO Capital » 05:00 01/22/21 01/22 05:00 01/22/21 05:00 HUBS HubSpot $388.29 / -7.47 (-1.89%) BMO Capital analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly HUBS HubSpot $388.29 / -7.47 (-1.89%) 12/14/20 HubSpot director sells 40K shares of common stock HUBS HubSpot $388.29 / -7.47 (-1.89%) 01/11/21 Piper Sandler HubSpot price target raised to $488 from $435 at Piper Sandler 01/11/21 Piper Sandler Bill.com price target raised to $140 from $120 at Piper Sandler 01/05/21 Wells Fargo HubSpot upgraded to Overweight from Equal Weight at Wells Fargo 01/05/21 Wells Fargo HubSpot upgraded to Overweight from Equal Weight at Wells Fargo HUBS HubSpot $388.29 / -7.47 (-1.89%) 11/05/20 HubSpot sees FY20 adjusted EPS $1.13-$1.15, consensus 95c 11/05/20 HubSpot sees Q4 adjusted EPS 21c-23c, consensus 18c 11/05/20 HubSpot reports Q3 adjusted EPS 28c, consensus 13c 08/05/20 HubSpot sees FY20 adjusted EPS 92c-96c, consensus 94c HUBS HubSpot $388.29 / -7.47 (-1.89%) 11/24/20 Target upgrade, Microsoft initiation among today's top calls on Wall Street 08/05/20 Fly Intel: After-Hours Movers
Downgrade	Sumitomo Mitsui Trust downgraded to Buy from Conviction Buy at Goldman Sachs » 04:58 01/22/21 01/22 04:58 01/22/21 04:58 SUTNY Sumitomo Mitsui Trust $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SUTNY Sumitomo Mitsui Trust $0.00 / + (+0.00%) 07/08/20 Goldman Sachs Sumitomo Mitsui Trust upgraded to Conviction Buy from Neutral at Goldman Sachs 06/10/20 Daiwa Sumitomo Mitsui Trust upgraded to Outperform from Neutral at Daiwa
Initiation	Store Capital resumed with a Neutral at Goldman Sachs » 04:56 01/22/21 01/22 04:56 01/22/21 04:56 STOR Store Capital $31.43 / +0.07 (+0.22%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings STOR Store Capital $31.43 / +0.07 (+0.22%) 01/21/21 Store Capital announces January rent collections of 91% 01/11/21 Store Capital announces acquisition activity for 2020 12/22/20 Store Capital announces December rent collections of 90% 11/23/20 Store Capital announces November rent collections of 90% STOR Store Capital $31.43 / +0.07 (+0.22%) 12/16/20 Baird Store Capital downgraded to Neutral from Outperform at Baird 12/11/20 Truist Store Capital price target raised to $30 from $27 at Truist 12/10/20 Wells Fargo Store Capital upgraded to Overweight from Equal Weight at Wells Fargo 12/10/20 Wells Fargo Store Capital upgraded to Overweight from Equal Weight at Wells Fargo STOR Store Capital $31.43 / +0.07 (+0.22%) 08/05/20 Store Capital reports Q2 adjusted FFO 44c, consensus 44c
Initiation	Vereit resumed with a Sell at Goldman Sachs » 04:55 01/22/21 01/22 04:55 01/22/21 04:55 VER Vereit $35.91 / -0.49 (-1.35%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VER Vereit $35.91 / -0.49 (-1.35%) 01/05/21 Vereit announces December rent collection of 97% 12/02/20 Vereit reports November rent collection of 97% 08/11/20 Vereit and Ocean West acquire facility in Dallas for $246.7M VER Vereit $35.91 / -0.49 (-1.35%) 01/14/21 Mizuho Vereit upgraded to Buy from Neutral at Mizuho 12/21/20 JPMorgan JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021 12/21/20 JPMorgan Vereit downgraded to Neutral from Overweight at JPMorgan 10/12/20 Morgan Stanley Broadstone Net Lease initiated with an Overweight at Morgan Stanley VER Vereit $35.91 / -0.49 (-1.35%) 11/05/20 Vereit reports Q3 AFFO 15c, consensus 15c 08/06/20 Vereit reports Q2 AFFO 15c, consensus 15c
Conference/Events	MKM Partners entertainment/video analysts hold analyst/industry conference call » 04:55 01/22/21 01/22 04:55 01/22/21 04:55 Entertainment/Video Games… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

TBK
Today at 08:00

Triumph Bancorp - TBK Conference Calls
PPG
Today at 08:00

PPG - PPG Conference Calls
EDU
Today at 08:00

New Oriental Education - EDU Conference Calls
HBAN
Today at 08:30

Huntington Bancshares - HBAN Conference Calls
SLB
Today at 08:30

Schlumberger - SLB Conference Calls
BMTC
Today at 08:30

Bryn Mawr Bank - BMTC Conference Calls
KSU
Today at 08:45

Kansas City Southern - KSU Conference Calls
TRST
Today at 09:00

Trustco Bank - TRST Conference Calls
DNMR
Today at 09:00

Danimer Scientific - DNMR Conference Calls
ALLY
Today at 09:00

Ally Financial - ALLY Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley $4.75-4.95 11.5M Shares PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities $13.00-14.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright $7.50-8.00 SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright $2.42 25.974M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Johnson Outdoors reports Q4 EPS $1.53, one estimate 80c

TODAY'S FREE FLY STORIES

Get Full Fly Access